Your browser doesn't support javascript.
loading
The Effect of SF3B1 Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer.
Leeksma, Alexander C; Derks, Ingrid A M; Kasem, M Haidar; Kilic, Emine; de Klein, Annelies; Jager, Martine J; van de Loosdrecht, Arjan A; Jansen, Joop H; Navrkalova, Veronika; Faber, Laura M; Zaborsky, Nadja; Egle, Alexander; Zenz, Thorsten; Pospisilova, Sarka; Abdel-Wahab, Omar; Kater, Arnon P; Eldering, Eric.
Afiliação
  • Leeksma AC; Department of Hematology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands.
  • Derks IAM; Department of Experimental Immunology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands.
  • Kasem MH; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), Amsterdam, Netherlands.
  • Kilic E; Department of Experimental Immunology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands.
  • de Klein A; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), Amsterdam, Netherlands.
  • Jager MJ; Translational Functional Cancer Genomics, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • van de Loosdrecht AA; Department of Ophthalmology and Clinical Genetics Erasmus MC, Rotterdam, Netherlands.
  • Jansen JH; Department of Ophthalmology and Clinical Genetics Erasmus MC, Rotterdam, Netherlands.
  • Navrkalova V; Department of Ophthalmology, LUMC, Leiden, Netherlands.
  • Faber LM; Department of Hematology, Amsterdam University Medical Centers, Location VUMC, Amsterdam, Netherlands.
  • Zaborsky N; Laboratory of Hematology, Department Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • Egle A; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Center of Molecular Medicine, CEITEC, Masaryk University, Brno, Czechia.
  • Zenz T; Department of Internal Medicine, Rode Kruis Ziekenhuis, Beverwijk, Netherlands.
  • Pospisilova S; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.
  • Abdel-Wahab O; Department of Internal Medicine III with Haematology, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria.
  • Kater AP; Department of Internal Medicine III with Haematology, Cancer Cluster Salzburg, Salzburg, Austria.
  • Eldering E; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.
Front Oncol ; 10: 609409, 2020.
Article em En | MEDLINE | ID: mdl-33585229
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda